Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All phase TMR | Experimental | TMR during every stage of sleep |
|
| Slow-wave sleep (SWS) only TMR | Experimental | TMR during slow-wave sleep only |
|
| Reduced frequency TMR | Experimental | TMR during only subset of sessions |
|
| Sham TMR | Sham Comparator | Patients receive no TMR |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Targeted Memory Reactivation (TMR) | Other | Targeted memory reactivation (TMR) refers to the process of playing audio cues associated with specific learned material quietly during sleep in order to strengthen consolidation of specific memories during sleep. |
| Measure | Description | Time Frame |
|---|---|---|
| Wolf Motor Function Test (WMFT) | The WMFT evaluates upper extremity function on a continuous scale. It measures the time it takes to perform 15 different tasks, with a time limit of 120 s per task. | change from baseline at 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function | The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale. | change from baseline at 6 weeks |
| Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marc W Slutzky, MD/PhD | Contact | 312-503-4653 | mslutzky@northwestern.edu |
| Name | Affiliation | Role |
|---|---|---|
| Marc W Slutzky, MD/PhD | Northwestern University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Northwestern University | Recruiting | Chicago | Illinois | 60611 | United States |
Clinical functional outcomes and analyzed EMG (co-activation) will be uploaded and shared upon publication.
IPD and associated analytic code will be made available upon publication of research results and will remain available for the duration of the funded project.
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Outcomes assessors and participant are blinded to groups.
The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale. |
| change from baseline at 10 weeks |
| Motor Activity Log (MAL) | The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living. | change from baseline at 6 weeks |
| Motor Activity Log (MAL) | The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living. | change from baseline at 10 weeks |
| Modified Ashworth Scale | The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested. | change from baseline at 6 weeks |
| Modified Ashworth Scale | The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested. | change from baseline at 10 weeks |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |